140 related articles for article (PubMed ID: 32509095)
1. Expression and clinical significance of Gal-3 and NFκB pathway-related factors in epithelial ovarian carcinoma.
Luk HM; Wang DY; Xie LL; Liu XY; Xu GC; Lu HW
Int J Clin Exp Pathol; 2020; 13(5):1197-1205. PubMed ID: 32509095
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κB pathway.
Lu H; Liu Y; Wang D; Wang L; Zhou H; Xu G; Xie L; Wu M; Lin Z; Yu Y; Li G
Tumour Biol; 2016 Aug; 37(8):11469-77. PubMed ID: 27012551
[TBL] [Abstract][Full Text] [Related]
3. Galectin-1 promotes tumor progression via NF-κB signaling pathway in epithelial ovarian cancer.
Chen L; Yao Y; Sun L; Tang J
J Cancer; 2017; 8(18):3733-3741. PubMed ID: 29151961
[No Abstract] [Full Text] [Related]
4. Galectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer.
Liu Y; Xie L; Wang D; Li D; Xu G; Wang L; Zhou H; Yu Y; Lin Z; Lu H
Cancer Manag Res; 2018; 10():3963-3971. PubMed ID: 30310317
[TBL] [Abstract][Full Text] [Related]
5. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
[TBL] [Abstract][Full Text] [Related]
6. High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion.
Kim HJ; Jeon HK; Cho YJ; Park YA; Choi JJ; Do IG; Song SY; Lee YY; Choi CH; Kim TJ; Bae DS; Lee JW; Kim BG
Eur J Cancer; 2012 Aug; 48(12):1914-21. PubMed ID: 22386573
[TBL] [Abstract][Full Text] [Related]
7. Expression and functions of galectin-7 in ovarian cancer.
Labrie M; Vladoiu MC; Grosset AA; Gaboury L; St-Pierre Y
Oncotarget; 2014 Sep; 5(17):7705-21. PubMed ID: 25277199
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma.
Kim MK; Sung CO; Do IG; Jeon HK; Song TJ; Park HS; Lee YY; Kim BG; Lee JW; Bae DS
Int J Clin Oncol; 2011 Aug; 16(4):352-8. PubMed ID: 21327452
[TBL] [Abstract][Full Text] [Related]
9. [Expression of lnc-MyD88 and its relationship with the prognosis of patients with epithelial ovarian cancer].
Zhu Y; Huang JM; Zhang GN; Li JM; Huang J
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):117-124. PubMed ID: 35184472
[No Abstract] [Full Text] [Related]
10. Clinical significance of galectin-7 in epithelial ovarian cancer.
Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
[No Abstract] [Full Text] [Related]
12. Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer.
Zhang P; Zhang P; Shi B; Zhou M; Jiang H; Zhang H; Pan X; Gao H; Sun H; Li Z
Cell Death Dis; 2014 Jan; 5(1):e991. PubMed ID: 24407244
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 regulates chemotherapy sensitivity in epithelial ovarian carcinoma via regulating mitochondrial function.
Wang D; You D; Li L
J Toxicol Sci; 2019; 44(1):47-56. PubMed ID: 30626779
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
15. High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer.
Han GH; Yun H; Chung JY; Kim JH; Cho H
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999629
[TBL] [Abstract][Full Text] [Related]
16. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
[TBL] [Abstract][Full Text] [Related]
17. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
[TBL] [Abstract][Full Text] [Related]
18. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
[TBL] [Abstract][Full Text] [Related]
19. Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer.
Wu Y; You Y; Chen L; Liu Y; Liu Y; Lou W; Fu F
Gland Surg; 2022 Apr; 11(4):687-701. PubMed ID: 35531115
[TBL] [Abstract][Full Text] [Related]
20. Mesothelium expression of vascular cell adhesion molecule-1 (VCAM-1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC).
Scalici JM; Arapovic S; Saks EJ; Atkins KA; Petroni G; Duska LR; Slack-Davis JK
Cancer; 2017 May; 123(6):977-984. PubMed ID: 28263384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
